Evidence map›Paper›PMID 29030541›Full record

ArticleNature communications2017

Inference of RNA decay rate from transcriptional profiling highlights the regulatory programs of Alzheimer's disease.

Rached Alkallas, Lisa Fish, Hani Goodarzi, Hamed S Najafabadi

Erratum issuedAbstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 74 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. A genome-wide association meta-analysis of all-cause and vascular dementia.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Pooled it
  2. Article
  3. RBFOX1 association with age at onset of Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Chemoselective Proteomics, Zinc Fingers, and a Zinc(II) Model for HAngewandte Chemie (International ed. in English) · 2024
    Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Rached AlkallasDepartment of Human Genetics, McGill University, Montreal, QC, Canada, H3A 0C7.
Lisa FishDepartment of Biochemistry and Biophysics, University of California, San Francisco, CA, 94158, USA.
Hani GoodarziDepartment of Biochemistry and Biophysics, University of California, San Francisco, CA, 94158, USA.
Hamed S NajafabadiDepartment of Human Genetics, McGill University, Montreal, QC, Canada, H3A 0C7. hamed.najafabadi@mcgill.ca.ORCID http://orcid.org/0000-0003-2735-4231

Funding

Systematic dissection of an aberrant splicing program driving cancer metastasisR00CA194077 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GOODARZI, HANI · 2016 to 2018
$746k
Structural RNA elements and their roles in post-transcriptional regulationK99CA194077 · NCI · ROCKEFELLER UNIVERSITY · PI GOODARZI, HANI · 2015 to 2015
$130k
NCI NIH HHS K99 CA194077NCI NIH HHS R00 CA194077
6 · The paper itself

Abstract

The abundance of mRNA is mainly determined by the rates of RNA transcription and decay. Here, we present a method for unbiased estimation of differential mRNA decay rate from RNA-sequencing data by modeling the kinetics of mRNA metabolism. We show that in all primary human tissues tested, and particularly in the central nervous system, many pathways are regulated at the mRNA stability level. We present a parsimonious regulatory model consisting of two RNA-binding proteins and four microRNAs that modulate the mRNA stability landscape of the brain, which suggests a new link between RBFOX proteins and Alzheimer's disease. We show that downregulation of RBFOX1 leads to destabilization of mRNAs encoding for synaptic transmission proteins, which may contribute to the loss of synaptic function in Alzheimer's disease. RBFOX1 downregulation is more likely to occur in older and female individuals, consistent with the association of Alzheimer's disease with age and gender."mRNA abundance is determined by the rates of transcription and decay. Here, the authors propose a method for estimating the rate of differential mRNA decay from RNA-seq data and model mRNA stability in the brain, suggesting a link between mRNA stability and Alzheimer's disease."

Indexed as

Models, BiologicalRNA StabilityAlzheimer DiseaseAnimalsBrainCell LineGene Expression ProfilingHumansMiceMicroRNAsRNA, MessengerRNA Splicing FactorsTranscription, GeneticTranscriptomeTristetraprolinMicroRNAsRBFOX1 protein, humanRNA, MessengerRNA Splicing FactorsTristetraprolinZFP36 protein, human

Identifiers

PMID29030541
PMCPMC5714957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.